An observational study in Three Dimension, Digital Tomosynthesis and Digital Mammography, sponsored by The General Authority for Teaching Hospitals and Institutes. Completed at 1 site in Egypt. Open to female participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2025-08-28.
Sponsored by The General Authority for Teaching Hospitals and Institutes · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aimed to compare the supremacy of (3D) tomosynthesis versus (2D) digital mammography in the diagnosis of benign breast lesions in asymptomatic females.
Most of the breast lesions are benign, but much concern is given to malignant lesions because breast cancer is the most common malignancy in women.
Mammography is the only study for screening in asymptomatic patients, and it is the initial imaging study in the diagnosis of symptomatic patients, with a sensitivity for suspicious lesions of 86% and a specificity of 57%.
In recent years, a significant effort has been expended to develop new approaches to breast imaging, one of which is the use of digital breast tomosynthesis (DBT), which is a pseudo three-dimensional digital mammography system that produces a series of thin-section reconstructed images from low-dose X-ray projections at multiple angles.
The General Authority for Teaching Hospitals and Institutes is the lead sponsor of 8 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This retrospective study was conducted on patients referred to the Diagnostic Radiology Department at Damanhur Educational Hospital and Tanta University.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Women with benign breast lesions.
Exclusion Criteria:
Categorized 130 women aged from 30 to 40 years.
Device: Three-dimensional Digital Breast Tomosynthesis · Device: Two-dimensional Digital Mammography
Categorized 115 women aged from 40 to 50 years.
Device: Three-dimensional Digital Breast Tomosynthesis · Device: Two-dimensional Digital Mammography
Categorized 10 females aged above 50 years.
Device: Three-dimensional Digital Breast Tomosynthesis · Device: Two-dimensional Digital Mammography
Patients underwent three-dimensional digital breast tomosynthesis.
Patients underwent two-dimensional digital mammography
Correlation between imaging findings and the final diagnosis
Correlation between imaging findings and the final diagnosis was calculated.
Time frame: 6 months post-procedure
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Ran from Jun 2024 to primary completion in May 2025, 11 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The General Authority for Teaching Hospitals and Institutes